- 01 Every 483 auto-classified to the relevant Six System subsystem
- 02 Per-system intelligence feeds weighted by citation frequency
- 03 FDA inspection checklists per system owner — not generic GMP questions
- 04 Cross-system dependency mapping for cascading citations
Cited Across All Six Systems
Each observation maps to a specific QSIT system. The system owners who needed this intelligence either never received it or received it weeks late.
Critical SOPs still in draft during active manufacturing — QCU oversight gaps across CAPA, OOS, and batch records
Apothecary Pharma LLC
May 15, 2025
The quality control unit had not finalized critical SOPs — including CAPA, OOS Results, and Batch Records — that remained in draft during active manufacturing. Batch records were not reviewed before distribution, and cleanroom certification reports were not reviewed by QA before producing sterile products.
Why System Owners Are Not Audit-Ready
The gap between what FDA is citing per system and what system owners are preparing for is structural.
Challenge 1/6
4,000+ Observations Per Year — No Human Can Categorise Them All
- 01Most quality teams review only a fraction, missing observations relevant to their systems
- 02Manual categorisation is subjective — the same observation gets tagged differently by different analysts
- 03By the time a trend is visible through manual review, it has been active for 6-12 months
Audit Readiness by Six Systems in FDA Tracker
1.Automatic Observation-to-System Classification
FDA Tracker classifies every 483 observation against FDA's Six System framework. AI agents parse observation text, identify the primary system, and flag cross-system dependencies.
2.System-Specific Intelligence Feeds
Each system has its own intelligence feed showing observations, trends, and citation frequency. System owners subscribe to their feed and receive only what is relevant to their area.
3.Citation Trend Analytics per System
FDA Tracker tracks citation frequency for each system over time, showing which systems face increasing FDA scrutiny. System owners see trends before they become industry talking points.
4.System-Specific Audit Checklists
For each system, FDA Tracker generates an audit readiness checklist weighted by citation frequency — the most commonly cited gaps appear first. Each system owner gets a focused, actionable checklist.
5.Cross-System Risk Visibility
FDA Tracker maps dependencies across systems — showing how a Quality System CAPA failure connects to a Production System validation gap. The Head of Quality sees a unified view of cross-system risk.
6.Continuous Readiness Monitoring
Instead of a 4-6 week pre-inspection scramble, FDA Tracker provides continuous monitoring. When FDA shifts focus, system owners are alerted and checklists update automatically.
FDA Sources
AI Classification
Six System Feeds
Inputs
System Feed Engine
LeucineOS Agent
Outputs
Inputs
Trend Analytics Engine
LeucineOS Agent
Outputs
Inputs
Checklist Generator
LeucineOS Agent
Outputs
Inputs
Cross-System Risk Engine
LeucineOS Agent
Outputs
Inputs
Continuous Monitor
LeucineOS Agent
Outputs
How FDA Tracker Solves This
Automated QSIT classification, per-system checklists, and continuous readiness monitoring.
Every Observation Classified by FDA's Six System Inspection Framework
FDA Tracker classifies every 483 observation and warning letter finding against the QSIT Six System framework. AI agents parse observation text, identify primary and secondary systems, and route intelligence to system owners automatically.
Capabilities
- Automatic QSIT system classification for every FDA enforcement action
- Cross-system dependency detection when observations span multiple systems
- Per-system intelligence feeds weighted by citation frequency
- Historical enforcement data searchable by system, dosage form, and facility type
The Shift
From generic audit preparation to system-specific, enforcement-data-driven readiness.
| Manual Approach | FDA Tracker | |
|---|---|---|
| Observation categorisation | One analyst reading 483s manually — 45 min per 483, covering a fraction of FDA output | Every observation auto-classified to the relevant Six System subsystem within minutes of publication |
| System owner intelligence | Periodic email summaries from regulatory analyst — same cadence for all systems | Dedicated per-system intelligence feeds with citation frequency weighting and trend analytics |
| Audit checklists | Generic checklists treating all six systems equally — static, updated annually | System-specific checklists weighted by current enforcement data — updated continuously |
| Cross-system visibility | Observations categorised into a single system — cross-system dependencies invisible | Cross-system dependency mapping showing how citations in one system propagate to others |
| Trend detection | Trends discovered at conferences or through consultant briefings — 12-18 months behind | Real-time system-level citation trends with quarter-over-quarter comparison and emerging signal detection |
| Actionability | No feedback loop — intelligence sent but no tracking of whether it was reviewed or acted on | Structured checklist completion with auditable records of review and response |
Who Benefits
Each system owner gets intelligence tailored to their area — while the Head of Quality sees unified readiness across all six systems.
VP Quality / Head of Quality
Unified visibility across all six systems
- Real-time readiness scores per system across the manufacturing network
- Cross-system risk mapping showing where citations in one system indicate gaps in another
- Data-driven resource allocation — direct audit preparation effort where citation frequency is highest
- Evidence-based reporting to leadership on regulatory preparedness posture
System Owner / QA Manager
Focused intelligence for your system — not the whole 483
- See only observations tagged to your system with citation frequency weighting
- System-specific audit checklists you can action immediately — not generic GMP questions
- Trend analytics showing whether your system's citation rate is increasing or stable
- Compare your system's readiness against industry-wide citation patterns
Director of Quality Operations / Compliance
Auditable regulatory intelligence programme
- Demonstrate systematic industry monitoring when FDA asks "how do you track enforcement trends?"
- Closed-loop tracking from industry observation → system owner review → facility self-assessment
- Exportable audit readiness reports per system for management review and regulatory submissions
- Replace ad-hoc email distribution with structured, searchable intelligence infrastructure
Platform Performance
Based on FDA Tracker's automated classification versus manual analyst workflows.
System Classification
Of FDA observations automatically classified to the relevant Six System subsystem — replacing manual analyst categorisation
System Coverage
Complete audit readiness coverage across all six QSIT systems with dedicated intelligence feeds and checklists per system
Categorisation Time
Less time categorising — FDA Tracker classifies each 483 to its QSIT system in seconds versus 45 minutes of manual analyst review
Trend Detection
Earlier detection of emerging enforcement trends by system — before conference presentations or consultant briefings
Powered by
FDA Tracker
Real-time regulatory intelligence — 483 observations, warning letters, inspection trends, and establishment profiles across the pharmaceutical industry.
Explore FDA TrackerYour system owners are all waiting for the same overloaded analyst to read the same 483s. FDA Tracker classifies every observation by system automatically and gives each owner their own enforcement-weighted intelligence feed.
